KDNY
Chinook Therapeutics, Inc. Common Stock
KDNY
KDNY
Delisted
KDNY was delisted on the 10th of August, 2023.
70 hedge funds and large institutions have $93.9M invested in Chinook Therapeutics, Inc. Common Stock in 2020 Q3 according to their latest regulatory filings, with 7 funds opening new positions, 14 increasing their positions, 29 reducing their positions, and 27 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
less capital invested
Capital invested by funds: $ → $
less funds holding
Funds holding: →
less repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
74% less first-time investments, than exits
New positions opened: 7 | Existing positions closed: 27
Holders
70
Holding in Top 10
–
Calls
$29K
Puts
$25K
Top Buyers
| 1 | +$4.98M | |
| 2 | +$1.53M | |
| 3 | +$1.41M | |
| 4 |
SCM
Suvretta Capital Management
New York
|
+$822K |
| 5 |
Ensign Peak Advisors
Salt Lake City,
Utah
|
+$625K |
Top Sellers
| 1 | -$7.79M | |
| 2 | -$1.09M | |
| 3 | -$808K | |
| 4 |
PAM
Panagora Asset Management
Boston,
Massachusetts
|
-$641K |
| 5 |
Renaissance Technologies
New York
|
-$633K |